SOPAT GmbH and Malvern Panalytical announce a distribution agreement for US market
SOPAT GmbH announced a distribution agreement with Malvern Panalytical. Malvern Panalytical is now the exclusive distributor for a complete range of SOPAT photo-optical image analysis instrumentation and software in the United States of America.
The founders of SOPAT GmbH: Jörn Emmerich, CTO (left) and Dr. Sebastian Maaß, CEO (right)
SOPAT GmbH
“We are thrilled to be working together with Malvern Panalytical in the US market. Having such a strong partner on our side helps us to get in touch with great potential business opportunities on this side of the world. Malvern Panalytical provides a commercial and technical support infrastructure required by our customers in academia and the industry for research and production monitoring. In addition, we are happy to learn from their wealth of experience in this diverse market. We do share the same values and seek the best quality to enhance the productivity of our clients’ processes, both saving resources and reducing costs. Therefore, we are delighted to be able to offer our product range to US customers through Malvern Panalytical.” said Dr. Sebastian Maaß CEO& co-founder, SOPAT GmbH.
“We are excited to bring this innovative, real-time image analysis technology to our customers in the United States. High-resolution visualization and quantitative analysis of particulate systems in situ and in near real time is an important enhancement to the characterization toolkit we deliver to research scientists and process engineers in many industries. SOPAT technology is complementing our range of solutions for on-line and in-process characterization and together with applications expertise of our technical team will deliver added value to our customers working on optimizing their products and processes.” said Alon Vaisman, Head of Sensors and Automation Solutions, Malvern Panalytical.
Most read news
Topics
Organizations
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
See the theme worlds for related content
Topic World Particle Analysis
Particle analysis methods allow us to study tiny particles in various materials and reveal their properties. Whether in environmental monitoring, nanotechnology or the pharmaceutical industry, particle analysis gives us a glimpse into a hidden world where we can decipher the composition, size and shape of particles. Experience the fascinating world of particle analysis!
Topic World Particle Analysis
Particle analysis methods allow us to study tiny particles in various materials and reveal their properties. Whether in environmental monitoring, nanotechnology or the pharmaceutical industry, particle analysis gives us a glimpse into a hidden world where we can decipher the composition, size and shape of particles. Experience the fascinating world of particle analysis!
Last viewed contents
Researchers find local environment directly influences adult stem cell reservoirs
Sticky stuff: Jacobs researchers reveal the sweet secret of caramel
The longer spilled oil lingers in freshwater, the more persistent compounds it produces - Weathering assessments of polar and non-polar petroleum components using Orbitrap and Fourier Transform Ion Cyclotron Resonance Mass Spectrometry.
First of 100 Arab Human Genomes Sequenced by Saudi Biosciences, Beijing Genomics Institute Shenzhen, and CLC bio
QIAGEN and Procognia Enter into a Marketing and Licensing Agreement Targeting the Field of Protein Glycoanalysis
Bio Nano Consulting chosen by a Top 5 pharma company to provide specialist nanotech product development services
Eurofins expands presence in Discovery Pharmacology with the acquisition of Pan Labs US
Discovery of a new gene critical in the development of lung and pancreatic cancers - Inhibition of this gene provokes a drastic reduction in the size of these tumors
PerkinElmer completes sale of medical imaging business to Varex Imaging
Proteros and University of Cincinnati, Drug Discovery Center establish collaboration to offer high-throughput screening services
Agilent Technologies and National University of Singapore Sign Research Collaboration Agreement for Lipidomics Research